AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings

BACKGROUND: Leprosy Type 1 reactions are difficult to treat and only 70% of patients respond to steroid treatment. Azathioprine has been used as an immune-suppressant and we tested its efficacy in treating leprosy T1R. METHODOLOGY: Randomised controlled trial adding azathioprine to steroid treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockwood, Diana N. J., Darlong, Joydeepa, Govindharaj, Pitchaimani, Kurian, Royce, Sundarrao, Pamidipani, John, Annamma S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373510/
https://www.ncbi.nlm.nih.gov/pubmed/28358815
http://dx.doi.org/10.1371/journal.pntd.0005348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373510/
https://www.ncbi.nlm.nih.gov/pubmed/28358815
http://dx.doi.org/10.1371/journal.pntd.0005348

Ejemplares similares